Epidermolysis bullosa is a rare and severe skin disease where patients have fragile skin that blisters and tears. A Mt.

Many Americans unknowingly misidentify various skin conditions, attributing every bump, patch or discoloration to ordinary ...

Financing co-led by new investor BRM Group and existing investor Pontifax. Lead program KM023 is a first-in-class oral TRPV3 inhibitor entering clinical development for the treatm ...

Scientists have long recognized human skin as a vibrant ecosystem that's home to millions of microorganisms. Our skin ...

When you apply sunscreen, remember the “two-finger rule” of applying two finger lengths of product to your face. Dr. Nazarian ...

InflaRx’s vilobelimab met the bar for futility in a Phase III trial for the rare skin disease pyoderma gangrenosum.